AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 294: G477-G488, 2008. First published November 29, 2007; doi:10.1152/ajpgi.00229.2007
0193-1857/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Corrigendum
Right arrow All Versions of this Article:
294/2/G477    most recent
00229.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narushima, S.
Right arrow Articles by Berg, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narushima, S.
Right arrow Articles by Berg, D. J.

INFLAMMATION/IMMUNITY/MEDIATORS

5-Lipoxygenase-derived lipid mediators are not required for the development of NSAID-induced inflammatory bowel disease in IL-10–/– mice

Seiko Narushima,1 Daniel DiMeo,2 Jun Tian,1 Juan Zhang,1 Dahzi Liu,1 and Daniel J. Berg1

1Department of Internal Medicine, 2Department of Pediatrics, University of Iowa College of Medicine, Iowa City, Iowa

Submitted 21 May 2007 ; accepted in final form 29 November 2007

Leukotrienes are potent lipid mediators derived from the metabolism of arachidonic acid by the enzyme 5-lipoxygenase (5-LO). Elevated levels of the proinflammatory leukotriene LTB4 have been found in preclinical models of inflammatory bowel disease (IBD) as well as in colon tissue from individuals with IBD. We therefore determined the extent to which absence of 5-LO-derived lipid mediators would alter the colitis in IL-10–/– mice, a model of human IBD. IL-10–/–/5-LO–/– mice were generated and were healthy. Absence of 5-LO did not alter the development of spontaneous colitis in IL-10-deficient mice. We then evaluated the extent to which absence of 5-LO would alter the development of NSAID-induced colitis in IL-10–/– mice. Absence of 5-LO did not delay the onset or alter the severity of inflammation in NSAID-treated IL-10–/– mice. At an early time point, 3 days after NSAID treatment was initiated, a qualitative increase in the number of dendritic cells and CD4+ T cells was noted in the colons of IL-10–/–/5-LO–/–; however, this difference was no longer present after 14 days of NSAID treatment. Absence of 5-LO did not alter the degree of neutrophil infiltration into the in this model. Absence of 5-LO does not alter the development of IFN-{gamma} producing Th1-type CD4+ T cells or IL-17 producing CD4+ T cells. Absence of 5-LO-derived mediators did not alter the expression of the adhesion molecules ICAM-1 and P-selectin. Development of colitis in IL-10–/– mice was associated with increased levels of the 5-LO-derived anti-inflammatory lipoxin LXA4. These studies demonstrate that 5-LO-derived leukotrienes are not required for the development or maintenance of spontaneous or NSAID-induced colonic inflammation in IL-10–/– mice.

cytokines; leukotriene; lipid mediators; inflammation



Address for reprint requests and other correspondence: D. Berg, Univ. of Iowa Hospitals, Dept. of Internal Medicine, C32-GH, 200 Hawkins Dr., Iowa City, IA 52242 (e-mail: daniel-j-berg{at}uiowa.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.